Onco-Innovations Limited
ONNVF
$0.78
$0.0913.32%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.00% | -34.84% | 31.39% | -68.49% | -1,159.13% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.44% | 2,476.61% | -96.39% | 219.64% | 45,538.46% |
| Change in Net Operating Assets | 238.35% | -203.47% | 249.76% | 43.29% | -746.20% |
| Cash from Operations | 67.15% | 9.50% | -18.10% | 24.01% | -728.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.98% | 15.42% | -15.90% | -36.89% | 1,430.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | 49.96% | -- |
| Cash from Financing | -99.97% | 7.05% | -10.07% | -36.70% | 1,317.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -504.58% | 185.40% | -150.08% | -65.06% | 2,404.93% |